1. Home
  2. JAGX vs SLE Comparison

JAGX vs SLE Comparison

Compare JAGX & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • SLE
  • Stock Information
  • Founded
  • JAGX 2013
  • SLE 2014
  • Country
  • JAGX United States
  • SLE United States
  • Employees
  • JAGX N/A
  • SLE N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • JAGX Health Care
  • SLE Consumer Discretionary
  • Exchange
  • JAGX Nasdaq
  • SLE Nasdaq
  • Market Cap
  • JAGX 3.4M
  • SLE 4.0M
  • IPO Year
  • JAGX N/A
  • SLE 2019
  • Fundamental
  • Price
  • JAGX $2.40
  • SLE $5.30
  • Analyst Decision
  • JAGX Strong Buy
  • SLE Strong Buy
  • Analyst Count
  • JAGX 1
  • SLE 2
  • Target Price
  • JAGX $60.00
  • SLE $100.00
  • AVG Volume (30 Days)
  • JAGX 98.6K
  • SLE 230.5K
  • Earning Date
  • JAGX 08-12-2025
  • SLE 08-13-2025
  • Dividend Yield
  • JAGX N/A
  • SLE N/A
  • EPS Growth
  • JAGX N/A
  • SLE N/A
  • EPS
  • JAGX N/A
  • SLE N/A
  • Revenue
  • JAGX $11,552,000.00
  • SLE $14,691,000.00
  • Revenue This Year
  • JAGX $22.41
  • SLE N/A
  • Revenue Next Year
  • JAGX $30.00
  • SLE $30.36
  • P/E Ratio
  • JAGX N/A
  • SLE N/A
  • Revenue Growth
  • JAGX 13.93
  • SLE N/A
  • 52 Week Low
  • JAGX $2.28
  • SLE $3.91
  • 52 Week High
  • JAGX $110.75
  • SLE $65.60
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 29.42
  • SLE 47.11
  • Support Level
  • JAGX $2.28
  • SLE $4.71
  • Resistance Level
  • JAGX $2.79
  • SLE $6.81
  • Average True Range (ATR)
  • JAGX 0.16
  • SLE 0.64
  • MACD
  • JAGX 0.11
  • SLE 0.23
  • Stochastic Oscillator
  • JAGX 16.00
  • SLE 43.98

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: